[1]
EvangelistaG.L., Sousa JuniorL.P. de, CarvallóL.C.M., PereiraL.S., BarataG.C., GomezM.H.D.A., RiccioE.P.S., NunesT.C. and GuimarãesM.C.M. 2023. Analysis of combination therapy with SGLT2 and DPP4 inhibitors in patients with Type 2 Diabetes Mellitus: an integrative review. Electronic Journal Collection Health. 23, 5 (May 2023), e12495. DOI:https://doi.org/10.25248/reas.e12495.2023.